Daily Brain Care | Breakthrough Brain Health Product May Hold The Key To Memory Loss скачать в хорошем качестве

Daily Brain Care | Breakthrough Brain Health Product May Hold The Key To Memory Loss

Daily Brain Care has a distinct competitive advantage over the vast majority of products in the brain health or nootropic space in the dietary supplement industry: a 12-month clinical trial that was conducted in patients with a memory disorder and cognitive dysfunction showed clinically and statistically significant improvements in cognitive and immune functioning without significant side effects. To our knowledge, no other product can match the significance of our findings (Lewis et al., 2013; Martin et al., 2017; Stillman et al., 2019)! Nonetheless, quite a few other studies in cognitive functioning have been conducted on two dietary compounds: Gingko Biloba and vitamin E. A meta-analysis among studies of Alzheimer's patients in 3- to 6-month treatment periods with 120 to 240 mg of Gingko Biloba revealed a small though the statistically significant effect on objective measures of cognitive function (Oken et al., 1998). Ernst (2002) found that Gingko Biloba appears to be effective at improving memory, concentration, fatigue, anxiety, and depressed mood. Mix and Crews (2000) found modest results in their study of cognitive-normal elderly subjects. Those subjects receiving Gingko Biloba improved more on a task assessing speed of processing abilities at the end of treatment and subjectively rated their abilities to remember as improved, compared to the placebo group. However, another study by Solomon et al. (2002) revealed that Gingko Biloba, when taken following manufacturer’s instructions, had no beneficial effect on memory and related mental functions in 230 physically and mentally healthy adults over the age of 60. No significant differences were found between baseline and follow-up comparing those subjects taking Gingko Biloba and those on placebo for any of the fourteen objective and subjective measures of learning, memory, attention, and concentration. While central nervous system oxidative stress has been theorized as a possible cause for Alzheimer's and dementia, researchers have found protective effects of vitamins E and C against cognitive decline (Paleologos et al., 1998; Perrig et al., 1997). Others found that 2,000 IU of vitamin E slowed the progression of moderately severe Alzheimer's in a group of patients, but no changes in cognitive functioning were found (Sano et al., 1997). While lipophilic antioxidants such as vitamin E appear to be neuroprotective and may help patients suffering from Alzheimer's (Morris et al., 1998), defining an optimal intake for preventive purposes is not possible at this time. Meanwhile, five FDA-approved medications are prescribed for Alzheimer's patients. Although Daily Brain Care is a dietary supplement and not regulated by the FDA as a drug, it might be useful to mention these compounds as competitors. For early to moderate stages of Alzheimer's, these cholinesterase inhibitors are used: Aricept (donepezil), Exelon (rivastigmine), and Razadyne (galantamine). These drugs are used to treat symptoms related to cognitive functioning, may help delay symptoms or slow them from worsening for a limited time, are not particularly efficacious, and as with all drugs have significant side effects. For moderate to severe stages of Alzheimer's, Namenda (memantine), Aricept (donepezil), and Namzaric (a combination of Namenda and Aricept) are the drugs prescribed, with Namenda being the most common. Namenda might temporarily improve some aspects of cognitive functioning, but will decline in efficacy over time and also has significant adverse effects.